Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
Owkin official newsroom · 行业原文收录 · 来源发布：Fri Jun 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收录：Thu Oct 08 2026 09:08:10 GMT+0000 (Coordinated Universal Time)
已保存的原文节选
NEW YORK & PARIS - 5th June, 2026 - Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. Owkin and Sanofi have collaborated since 2021 through a €90 millio
以上为带出处的原文节选，完整内容请阅读原始链接。自动收录与主题分类不等于事实核验。